|
Liposomal Bupivacaine Clinical Trials
4 actively recruiting trials across 3 locations
▼ -1 trial since June 2026
Also known as: Bupivacaine Liposome Injectable Suspension, Bupivacaine liposome, EXPAREL, Exparel
Pipeline
Phase 2: 1Phase 4: 2
Top Sponsors
- United States Naval Medical Center, Portsmouth1
- Masonic Cancer Center, University of Minnesota1
- Geisinger Clinic1
- Dezhou Hospital Qilu Hospital of Shandong University1
Indications
- Cancer3
- Osteoarthritis, Knee1
- Transoral Robotic Surgery1
- Post Operative Pain1
- Dysphagia, Oropharyngeal1
Other1 trial
Minneapolis, Minnesota1 trial
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
University of Minnesota/Masonic Cancer Center
Phase 2
Danville, Pennsylvania1 trial
Liposomal Bupivacaine and Transoral Robotic Surgery
Geisinger Medical Center
Portsmouth, Virginia1 trial
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
Naval Medical Center Portsmouth
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.